President Trump Links Tylenol Use During Pregnancy to Autism, Sparking Medical Community Backlash
President Donald Trump has claimed a link between Tylenol use during pregnancy and autism, a statement that has been widely disputed by medical experts and organizations.
President Donald Trump has claimed a link between Tylenol use during pregnancy and autism, a statement that has been widely disputed by medical experts and organizations.
On September 22, 2025, President Donald Trump announced that the Food and Drug Administration (FDA) would advise physicians that acetaminophen, commonly known as Tylenol, when used during pregnancy, may be associated with an increased risk of autism. He urged pregnant women to limit Tylenol use unless medically necessary.
Medical experts swiftly refuted these claims. The American College of Obstetricians and Gynecologists (ACOG) stated that there is no clear evidence linking acetaminophen use during pregnancy to autism or other developmental issues. ACOG emphasized that acetaminophen remains the recommended pain reliever for pregnant women when used appropriately.
Kenvue, the manufacturer of Tylenol, also contested the administration's assertions. The company highlighted that extensive research supports the safety of acetaminophen during pregnancy and expressed concern that the administration's statements could cause unnecessary alarm among expectant mothers.
The FDA has not confirmed any changes to acetaminophen labeling or guidelines. The agency continues to recommend that pregnant women consult healthcare providers before using any medication.
This development has sparked widespread discussion and concern among healthcare professionals and the public regarding the dissemination of medical information and its potential impact on public health.